Here is the detailed overview of Daclatasvir Tablet 30 mg with icons:
💊 Daclatasvir Tablet 30 mg
🧪 Nature / Drug Class
🔹 Direct-Acting Antiviral (DAA)
🔹 NS5A Inhibitor
🔹 Inhibits Hepatitis C Virus (HCV) replication and assembly
🩺 Purpose / Indications
✅ Used in combination with Sofosbuvir (and sometimes Ribavirin) for treating:
- 🦠 Chronic Hepatitis C (HCV) infection
- 🌍 Effective against multiple HCV genotypes (especially Genotype 3)
- 🧫 Used in patients with or without cirrhosis
- 👥 Suitable for adults and adolescents (under specialist care)
⚙️ Advantages
✔️ High sustained virologic response (SVR) rates
✔️ Short treatment duration (typically 12–24 weeks)
✔️ Oral, once-daily dosing
✔️ Useful in patients with HIV-HCV co-infection
📦 Common Packaging
📦 Tablet: 30 mg
💊 Supplied in blister packs (often 28 tablets per pack)
⚠️ Patient Advice / Precautions
🕐 Take once daily, same time every day
🍽️ May be taken with or without food
➕ Always used in combination therapy (never alone)
🧪 Monitor:
- HCV RNA levels
- Liver function
- Hemoglobin if used with ribavirin
⚠️ Dose may be reduced to 30 mg in patients on certain CYP3A4 inhibitors
🚫 Avoid in pregnancy if used with ribavirin
🧊 Storage
🌡️ Store at room temperature
🚫 Keep away from heat, light, and moisture
🧒 Store out of reach of children